Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers

Table 8

Detection of p53 immunohistochemical analysis.

	Sensitivity	Specificity	PPV^*1	NPV^*2	FPR^*3	FNR^*4	Accuracy
Pancreatic cancer	43.7%	100.0%	0.0%	56.2%	100.0%	35.7%	57.1%
Biliary tract cancer	55.5%	100.0%	0.0%	44.4%	100.0%	50.0%	69.2%
Pancreatobiliary cancer	48.0%	100.0%	0.0%	52.0%	100.0%	40.9%	61.7%

∗1PPV: positive predictive value.
∗2NPV: negative predictive value.
∗3FPR: false positive rate.
∗4FNR: false negative rate.